Brief: Ampio Receives Feedback From FDA On Ampio's Proposed Modifications To Special Protocol Assessment For Ampion Treatment Of Severe Osteoarthritis Of Knee

Ampio Pharmaceuticals

29/12/2020 14:22

Dec 29 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO RECEIVES FEEDBACK FROM THE FDA ON AMPIO'S PROPOSED
MODIFICATIONS TO THE SPECIAL PROTOCOL ASSESSMENT FOR AMPION
TREATMENT OF SEVERE OSTEOARTHRITIS OF THE KNEE
    * AMPIO PHARMACEUTICALS INC - FDA PROVIDED PRACTICAL
GUIDANCE FOR
AP-013 STUDY TO NAVIGATE PANDEMIC, AND TO COMPLETE STUDY WITHOUT
RE-RUNNING TRIAL

Source text for Eikon:  ID:nPn5m1LLHa 
Further company coverage:  AMPE.A 

 ((Reuters.Briefs@thomsonreuters.com;))